Teachers Retirement System of the State of Kentucky’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-85,655
Closed -$821K 1749
2022
Q3
$821K Buy
+85,655
New +$988K 0.01% 894
2022
Q1
$4.52M Buy
271,204
+55,271
+26% +$855K 0.04% 395
2021
Q4
$4.12M Buy
215,933
+23,304
+12% +$513K 0.04% 441
2021
Q3
$4.75M Buy
192,629
+43,253
+29% +$1.02M 0.04% 404
2021
Q2
$3.89M Buy
149,376
+5,514
+4% +$143K 0.04% 447
2021
Q1
$4.55M Buy
143,862
+45,115
+46% +$1.87M 0.04% 404
2020
Q4
$4.58M Buy
+98,747
New +$3.92M 0.05% 403
2020
Q3
Sell
-15,825
Closed -$434K 1767
2020
Q2
$434K Sell
15,825
-14,679
-48% -$483K 0.01% 1138
2020
Q1
$913K Sell
30,504
-14,709
-33% -$390K 0.01% 732
2019
Q4
$1.25M Buy
45,213
+29,572
+189% +$673K 0.01% 734
2019
Q3
$285K Buy
15,641
+9,041
+137% +$200K ﹤0.01% 1379
2019
Q2
$162K Buy
+6,600
New +$99.4K ﹤0.01% 1577

Other funds holding IOVA

Teachers Retirement System of the State of Kentucky's IOVA Position: Q4 2022 in Review

Teachers Retirement System of the State of Kentucky sold out of Iovance Biotherapeutics (IOVA) in Q4 2022, closing a stake of 85,655 shares — an estimated $821K sold.

Teachers Retirement System of the State of Kentucky first reported a position in IOVA in Q2 2019 and held it in 12 quarters. The position peaked at $4.75M in Q3 2021. 218 funds tracked by Wall St. Rank hold IOVA as of Q4 2022.

  • Teachers Retirement System of the State of Kentucky reported no remaining Iovance Biotherapeutics position as of Q4 2022 after selling out during the quarter.
  • Teachers Retirement System of the State of Kentucky sold 85,655 Iovance Biotherapeutics shares in Q4 2022, an estimated $821K.
  • Teachers Retirement System of the State of Kentucky first reported a position in Iovance Biotherapeutics in Q2 2019 and held it in 12 quarters.
  • Teachers Retirement System of the State of Kentucky's Iovance Biotherapeutics position peaked at $4.75M in Q3 2021.
  • 218 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2022.

Based on Teachers Retirement System of the State of Kentucky's 13F filing for Q4 2022, filed 22 Feb 2023.